Skip to main content

Provider

By Jessica Hagen | 03:57 pm | June 18, 2024
Patients in Switzerland will have access to Mika Health's psychological support offerings in conjunction with pharmaceutical therapy.
By HIMSS TV | 12:00 pm | June 18, 2024
In part two of a two-part series, Dr. Bruce Darrow, CMIO and interim CDIO at Mount Sinai Health System, discusses how the health system utilizes AI for predictive care, reading diagnostic images, and streamlining administrative operations.  
HIMSS24
By HIMSS TV | 06:09 pm | June 17, 2024
Dr. Harm Scherpbier, HealthShare Exchange CMIO, describes how the company's platform connects practices, payers and ACOs, allowing them to share patients’ data in real time across facilities to coordinate care seamlessly.  
HIMSS24
By HIMSS TV | 04:07 pm | June 17, 2024
Ran Balicer, HIMSS board of directors member, talks about the possibility of clinical digital support technology to personalize care by helping clinicians predict potential health issues for patients so they can be prevented.  
By Jessica Hagen | 03:20 pm | June 17, 2024
The company is now an in-network provider with numerous insurers and commercial and Medicare Advantage plans, expanding its reach to all 50 states.
By Jessica Hagen | 02:23 pm | June 17, 2024
Tx-LLM was fine-tuned from Google's Med-PaLM 2 and created to analyze a variety of chemical or biological entities to assist with the drug-discovery pipeline.
By HIMSS TV | 12:00 pm | June 17, 2024
In part one of a two-part series, Dr. Bruce Darrow, Mount Sinai Health System CMIO and interim CDIO, relays how patients may gain confidence in relying on AI instead of doctors as accuracy of pattern recognition and predictive models improve.  
By HIMSS TV | 04:53 pm | June 14, 2024
Aaron Gani, CEO and founder of RealizedCare, discusses the evolution of digital therapeutics, the FDA’s place in advancing them, keeping up with evolving technology, and the benefits of DTx modalities for the pharmaceutical industry.  
By Jessica Hagen | 03:54 pm | June 14, 2024
The telemedicine company's clinical president and its founder and CEO allegedly participated in a scheme to profit from providing easy access to Adderall for no valid medical purpose.
By HIMSS TV | 07:00 am | June 14, 2024
Andy Molnar, CEO of the Digital Therapeutics Alliance, discusses the definition of a digital therapeutic, companies in the DTx space, why the organization held its recent summit in D.C. and the status of the Prescription Digital Therapeutics Act.